Press Releases PolyPeptide Group AG

Equities

PPGN

CH1110760852

Market Closed - Swiss Exchange Other stock markets 09:01:55 08/05/2024 pm IST			5-day change	1st Jan Change
30.85 ^CHF	+0.65%		+1.82%	+76.08%

12/03	PolyPeptide Group AG Provides Earnings Guidance for 2024	CI
12/03	Transcript : PolyPeptide Group AG, 2023 Earnings Call, Mar 12, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hamlet BioPharma secures large scale Alpha1 peptide production in an agreement with Polypeptide Group	18/04	AQ
PolyPeptide announces results of the annual General Meeting 2024	10/04	EQ
PolyPeptide publishes invitation to the annual General Meeting 2024	19/03	EQ
PolyPeptide : publishes invitation to the annual General Meeting 2024	19/03	PU
PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow	12/03	EQ
PolyPeptide signs scientific collaboration agreement	31/23/31	EQ
PolyPeptide secures revolving credit facility	02/23/02	EQ
Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO	15/23/15	EQ
PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023	13/23/13	EQ
Hamlet Pharma secures long-term Alpha1 peptide production in an agreement with Polypeptide Group	12/23/12	AQ
PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs	10/23/10	EQ
PolyPeptide : launches new “Innovation Lab”	08/23/08	PU
PolyPeptide announces results of the annual General Meeting 2023	12/23/12	EQ
PolyPeptide appoints Juan-Jose Gonzalez as CEO and announces change of CFO	04/23/04	AQ
PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO	03/23/03	EQ
PolyPeptide publishes invitation to the annual General Meeting 2023	22/23/22	EQ
PolyPeptide reports weaker performance in 2022 - expects growth to recover in the second half of 2023	14/23/14	AQ
PolyPeptide reports weaker performance in 2022 – expects growth to recover in the second half of 2023	14/23/14	EQ
PolyPeptide: CEO of PolyPeptide resigns	30/23/30	EQ
PolyPeptide signs significant commercial agreement	19/22/19	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases PolyPeptide Group AG

Equities

PPGN

CH1110760852

Press Releases

Filters